Clinical Fellowship Program

Dystonia is a multifaceted neurological disorder.  Despite advances in clinical management and  research, the diagnosis of dystonia continues to be, far too often, delayed or missed. Although treatment options have expanded with the recent approval of botulinum neurotoxins and the success of deep brain stimulation, patients with dystonia continue to report difficulties in locating physicians who know how to evaluate their individual needs and to develop an appropriate treatment plan. In addition, there is a great need for better understanding of the disorder in its various clinical manifestations and for the development of better treatments.  This emphasizes the urgent need for training more experts in dystonia, which can be best achieved by additional fellowship training in movement disorders with special emphasis on dystonia.

DMRF is pleased to offer one-year clinical fellowships to support the training of exceptionally qualified physicians in preparation for their clinical and/or research career in movement disorders with emphasis on dystonia and a special competence in use of botulinum toxins.

In 2024, this program will support fellows through grants to the DMRF from Ipsen Biopharmaceuticals and Merz Therapeutics.

Congratulations to our 2024 Clinical Fellow and Mentor:

Tanziyah Muqeem, MD, PhD
Mentor: Nicole Calakos, MD, PhD
Duke University, Durham, North Carolina

Dr. Muqeem will begin her fellowship at Duke University in July 2024 and will spend the first year receiving clinical training while the second year will focus on clinical research.